What is the concern about Singulair (montelukast)?
Singulair is a major drug in asthma treatment – it is important to review recent developments and put these findings in perspective of overall asthma care for individual patients.
Singulair (montelukast)
Singulair (manufactured and marketed by Merck and Co.) is a drug of the so-called anti-leukotriene class that is used for control of symptoms of asthma and allergic rhinitis (hay fever). It was initially approved by the U.S. Food and Drug...
As things stand most people who are treated for depression are partially responsive or non-responsive to conventional antidepressant... Read more »
It seems recently, more than ever, I've been representing the phrase I once heard - "I'm so far behind, I think I'm FIRST!" In trying to... Read more »
Vitamin C is a powerful antioxidant that reduces arterial inflammation. The more vitamin C in your diet the lower your blood pressure and... Read more »
A recent study presented at a conference for the Consortium of Academic Health Centers for Integrative Medicine found that meditation... Read more »
Read Part 2: Jazz Up Holiday Cooking with Whole Grains Looking for something new and interesting to liven up holiday meals or take to a... Read more »
A new study suggests that children treated with Singulair missed fewer school days than those who took a placebo. Researchers say the kids who took... Read more »
Blocking a certain protein can prevent lung inflammation in mice who are exposed to cigarettes, researchers say. Cigarettes causes lung inflammation... Read more »
According to a new animal study, bilberry extract may reduce inflammation in colitis patients and offer an alternative to steroids. The scientists... Read more »
Researchers at the University of California, Davis have found that statins like Lipitor, Zocor, and Crestor may help lower inflammation in patients... Read more »
Researchers at the Methodist DeBakey Heart Center have found that a combination of Crestor (rosuvastatin) and Zetia (ezetimibe) reduces both LDL... Read more »